CHANDIGARH,15.10.25-
41st Annual National Workshop on Clinical Pharmacology (NWCP 2025) Commences at PGIMER, Chandigarh
The third day of NWCP 2025 at PGIMER took participants into the core of clinical pharmacology - understanding how medicines act inside the human body to ensure correct and safe dosing for every patient.
In an engaging session, Prof. Sandeep Kaushal, assisted by Dr. Rachna, explained Basic and Clinical Pharmacokinetics, using relatable examples to show how factors such as age, organ function, and disease alter drug response. This knowledge, he said, helps clinicians avoid both underdosing and adverse effects.
Later, delegates presented their prepared protocols, which were followed by an engaging discussion. Dr. Ashish Kakkar spoke about Innovative Trial Designs that help bring lifesaving drugs to patients faster without compromising safety. Prof. Samir Malhotra addressed how missing data in studies are managed transparently to maintain scientific integrity.
======================================
14th Workshop on Good Laboratory Practices (GLP)”
The Experimental Pharmacology Laboratory, Department of Pharmacology, PGIMER, Chandigarh, under the supervision of Prof. Bikash Medhi, successfully organized the “14th Workshop on Good Laboratory Practices (GLP)” on October 13, 2025. The workshop was supported by the Department of Health Research (DHR), Ministry of Health and Family Welfare, Government of India, and aimed to promote awareness, understanding, and implementation of GLP principles in biomedical and preclinical research across India.
The one-day workshop brought together scientists, researchers, and postgraduate students from various academic and research institutions. The inaugural session included Lamp Lighting and Saraswati Vandana, followed by a welcome address by Prof. Bikash Medhi, Organizing Chairman. The session emphasized the importance of maintaining high standards of quality assurance, data integrity, and reproducibility in research laboratories to meet international compliance norms.
The scientific sessions featured a series of interactive lectures by eminent speakers and experts from academia, research organizations, and the pharmaceutical industry.
Dr. Ekta Kapoor (NGCMA, New Delhi) delivered a detailed lecture on the History and Development of GLP, highlighting the role of the Organisation for Economic Co-operation and Development (OECD), Mutual Acceptance of Data (MAD), and the National GLP Compliance Monitoring Authority (NGCMA).
Prof. Bikash Medhi (PGIMER, Chandigarh) discussed Introduction to GLP, OECD Principles, and their Implications in Developing Nations.
Dr. Saurav Banarjee (Lupin Laboratory) spoke on Test Item Characterization for GLP Studies, emphasizing the critical aspects of test material quality and traceability.
Dr. Prabhu (Pondicherry) explained the Role of Quality Assurance Unit (QAU) in OECD GLP Accredited Laboratories.
Dr. Dhirendra Singh (IITR, Lucknow) shared insights on GLP Requirements for In Vivo Preclinical Toxicity Studies.
Dr. Sekhar Dhawan (Zydus, Ahmedabad) discussed the Role of Test Facility Management (TFM) in GLP Implementation.
Dr. A. B. Pant concluded the scientific session with a lecture on How to Conduct In-vitro Toxicity Studies in a GLP Environment.
The sessions were followed by a quiz competition to assess participants’ understanding of GLP principles. The workshop concluded with a valedictory ceremony at 5:00 PM, where certificates were distributed to all participants.
Prof. Bikash Medhi expressed gratitude to all speakers, delegates, and organizing committee members for their active participation and valuable contributions. He acknowledged the support of DHR for enabling such capacity-building initiatives that strengthen the foundation of ethical, reliable, and internationally acceptable biomedical research practices.